This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Strategy, led by Michael Saylor, plans to fund STRC dividends by selling Bitcoin, with a long-term goal to buy more B...
XRP trades near $1.45 as policy and liquidity headlines drive the 12-month outlook. Analysts map three potential path...
E-Estate unveils a June 13 Washington DC Summit to celebrate a year of tokenized real estate and map the sector’s inf...
In this story, meet brothers turned homegrown founders who built an in-house AI agent, then closed a $12 million seed...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A new analysis warns that social security checks could fall about 24% by 2032 if the trust fund dries up, though bene...
SpaceX AI projects Bitcoin to climb to $150,000–$250,000 by end-2026, but a key regulatory catch could cap gains. Mar...
Bitcoin strengthens as JPMorgan reports a renewed tilt toward crypto assets in the debasement trade, diverging from g...
SpaceX stock rose again Monday after Elon Musk signaled a possible $1 trillion in annual revenue by 2030, fueling a b...
As inflation keeps costs high, more households are assisting adult children. This report outlines practical, doable t...
Investors chasing a SpaceX IPO windfall risk turning luck into poor strategy. Experts warn the real lesson is risk ma...